Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer-Reference-Cited by-同舟云学术

Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer

Published:2019-10 Issue:1 Volume:29 Page:76-88.e7
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Lukey Michael J.,Cluntun Ahmad A.,Katt William P.,Lin Miao-chong J.,Druso Joseph E.,Ramachandran Sekar,Erickson Jon W.,Le Henry H.,Wang Zhihan-Emily,Blank Bryant,Greene Kai Su,Cerione Richard A.

Funder

NIH

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference39 articles.

1. From Krebs to clinic: glutamine metabolism to cancer therapy;Altman;Nat. Rev. Cancer,2016

2. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation;Asselin-Labat;Nat. Cell Biol.,2007

3. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism;Biancur;Nat. Commun.,2017

4. Expression of Gls and Gls2 glutaminase isoforms in astrocytes;Cardona;Glia,2015

5. The rate of glycolysis quantitatively mediates specific histone acetylation sites;Cluntun;Cancer Metab.,2015

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting amino acid-metabolizing enzymes for cancer immunotherapy;Frontiers in Immunology;2024-08-14

2. Altered expression of GLS2 indicates a poor prognosis and correlates with clinicopathological features of oral squamous cell carcinoma;International Journal of Oral and Maxillofacial Surgery;2024-08

3. Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma;Cell Reports Medicine;2024-08

4. Mitochondrial inhibitors: a new horizon in breast cancer therapy;Frontiers in Pharmacology;2024-07-04

5. Glutaminolysis is a Potential Therapeutic Target for Kidney Diseases;Diabetes, Metabolic Syndrome and Obesity;2024-07